119 related articles for article (PubMed ID: 1836240)
1. Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries.
Egashira K; Inou T; Imaizumi T; Tomoike H; Takeshita A
Jpn Circ J; 1991 Nov; 55(11):1050-6. PubMed ID: 1836240
[TBL] [Abstract][Full Text] [Related]
2. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans.
Chu A; Morris KG; Kuehl WD; Cusma J; Navetta F; Cobb FR
Circulation; 1989 Dec; 80(6):1627-35. PubMed ID: 2557173
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracoronary infusion of atrial natriuretic peptide on pacing-induced myocardial ischemia in patients with effort angina pectoris.
Kai H; Egashira K; Hirooka Y; Sugimachi M; Suzuki S; Kuga T; Mohri K; Urabe Y; Inou T; Takeshita A
Coron Artery Dis; 1994 Dec; 5(12):987-94. PubMed ID: 7728299
[TBL] [Abstract][Full Text] [Related]
4. Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs.
Chu A; Cobb FR
Circ Res; 1987 Oct; 61(4):485-91. PubMed ID: 2958167
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure.
Ehara S; Nakamura Y; Matsumoto K; Hasegawa T; Shimada K; Takagi M; Hanatani A; Izumi Y; Terashima M; Yoshiyama M
Heart Vessels; 2013 Sep; 28(5):596-605. PubMed ID: 23014927
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris.
Lai CP; Egashira K; Tashiro H; Narabayashi H; Koyanagi S; Imaizumi T; Takeshita A
Circulation; 1993 Jan; 87(1):144-51. PubMed ID: 8419001
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.
Valsson F; Lundin S; Kirnö K; Hedner T; Houltz E; Saito Y; Ricksten SE
Anesth Analg; 1999 Feb; 88(2):279-85. PubMed ID: 9972741
[TBL] [Abstract][Full Text] [Related]
8. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
9. Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog.
Bauman RP; Rembert JC; Himmelstein SI; Klotman PE; Greenfield JC
Circulation; 1987 Sep; 76(3):705-9. PubMed ID: 2957114
[TBL] [Abstract][Full Text] [Related]
10. Myocardial circulatory and metabolic effects of atrial natriuretic peptide after coronary artery bypass grafting.
Valsson F; Lundin S; Kirnö K; Hedner T; Saito Y; Ricksten SE
Anesth Analg; 1996 Nov; 83(5):928-34. PubMed ID: 8895265
[TBL] [Abstract][Full Text] [Related]
11. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs.
Chu A; Murray JJ; Lin CC; Russell M; Hagen PO; Cobb FR
Am J Physiol; 1990 Aug; 259(2 Pt 2):H340-5. PubMed ID: 1974738
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
Michaels AD; Klein A; Madden JA; Chatterjee K
Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
[TBL] [Abstract][Full Text] [Related]
13. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
14. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables.
Okumura K; Yasue H; Fujii H; Kugiyama K; Matsuyama K; Yoshimura M; Jougasaki M; Kikuta K; Kato H; Tanaka H
J Am Coll Cardiol; 1995 Feb; 25(2):342-8. PubMed ID: 7829786
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcitonin gene-related peptide on normal and atheromatous vessels and on resistance vessels in the coronary circulation in humans.
Ludman PF; Maseri A; Clark P; Davies GJ
Circulation; 1991 Nov; 84(5):1993-2000. PubMed ID: 1934374
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide augments coronary collateral blood flow: a study during coronary angioplasty.
Kyriakides ZS; Sbarouni E; Antoniadis A; Iliodromitis EK; Mitropoulos D; Kremastinos DT
Clin Cardiol; 1998 Oct; 21(10):737-42. PubMed ID: 9789694
[TBL] [Abstract][Full Text] [Related]
17. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.
Nitenberg A; Valensi P; Sachs R; Dali M; Aptecar E; Attali JR
Diabetes; 1993 Jul; 42(7):1017-25. PubMed ID: 8513969
[TBL] [Abstract][Full Text] [Related]
18. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P.
Egashira K; Suzuki S; Hirooka Y; Kai H; Sugimachi M; Imaizumi T; Takeshita A
Hypertension; 1995 Feb; 25(2):201-6. PubMed ID: 7531175
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man.
Herrmann HC; Rosenthal AD; Davis CA
Am Heart J; 1990 Aug; 120(2):308-15. PubMed ID: 2143351
[TBL] [Abstract][Full Text] [Related]
20. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound.
Sudhir K; MacGregor JS; Barbant SD; Foster E; Fitzgerald PJ; Chatterjee K; Yock PG
J Am Coll Cardiol; 1993 Apr; 21(5):1261-8. PubMed ID: 8459086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
